Bristol-Myers Squibb Aktie News

Initiate Bristol-Myers Squibb (BMY) with Buy and $57 PT, driven by high-momentum launches, robust pipeline, and underappreciated growth portfolio outperformance. BMY's $13bn+ annual FCF, strong balance sheet, and disciplined capital returns provide downside protection and support ongoing R&D and M&A activity. Our above-consensus FY25/26 revenue forecasts reflect accelerating adoption of Opdivo,...

Investors love dividend stocks, especially the blue-chip variety, because they offer a significant income stream and have massive total return potential.

Bristol-Myers Squibb faces structural headwinds from legacy product losses, but its strong free cash flow and undervalued stock price provide downside protection. The recent $11B partnership with BioNTech signals management's ambition to revitalize growth and address long-term potential in oncology. Despite near-term 'dead money' concerns, BMY's deeply discounted valuation, while paying more th...

Investors love dividend stocks, especially high-yield ones, because they offer a significant income stream and have substantial total return potential.

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Abecma--U.S. FDA Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb's Cell Therapy Labels.

For income investors seeking a timely value stock to buy on the dip, former dividend darling Bristol-Myers Squibb (NYSE:BMY) may fit the bill as one of the top names to watch in the month of July.

Cigna sued Bristol Myers on Tuesday, accusing the drugmaker of violating federal antitrust law by maintaining a monopoly over a blockbuster multiple myeloma drug sold under the brand name Pomalyst.

Long-term bond yields continue to rise. But investors looking for income can still find plenty of attractive opportunities with dividend-paying stocks that have healthy yields. “23 stocks pay huge dividends. They should be a better bet than treasuries.” — Barron's Weekly. In Barron's, Steven Wieting, strategist at Citi Wealth, noted that a growing dividend is a tangible benefit for shareholders...